NCT05214482 2026-03-03
A Study of AK112 in Advanced Malignant Tumors
Akeso
Phase 1/2 Completed
Akeso
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Syndax Pharmaceuticals
University of Michigan Rogel Cancer Center
Sun Yat-sen University
Hospices Civils de Lyon